Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of randomized trials by Oberoi, Sapna et al.
1 
 
TITLE: Physical activity reduces fatigue in patients with cancer and hematopoietic stem 
cell transplant recipients: A systematic review and meta-analysis of randomized trials   
 
AUTHORS: 1Sapna Oberoi MD, DM, 1Paula D. Robinson MD, MSc, 2Danielle Cataudella 
3Nicole Culos-Reid PhD, 4Hailey Davis, 4Nathan Duong, 5Faith Gibson RN, PhD, 6Miriam 
Götte, PhD, 7Pamela Hinds RN, PhD, FAAN, 8Sanne L Nijhof MD, PHD, 4Deborah 
Tomlinson RN, 8Patrick van der Torre MSc, 1Sandra Cabral, 4,9L Lee Dupuis MScPhm, 
PhD and 4,10Lillian Sung MD, PhD 
  
AFFILIATIONS: 
1Pediatric Oncology Group of Ontario, Toronto, ON 
2Department of Pediatric Psychology, Children's Hospital, London Health Sciences 
Centre, London, ON 
3Faculty of Kinesiology, University of Calgary, Calgary, AB 
4Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, ON  
5Centre for Outcomes and Experiences Research in Children's Health, Illness, and 
Disability, Great Ormond Street Hospital for Children NHS Foundation Trust, London, 
and School of Health Sciences, University of Surrey, Guildford, UK 
6University Hospital Essen, Center for Child and Adolescent Medicine, Department of 
Pediatric Hematology/Oncology, Essen, Germany 
7Department of Nursing Science, Professional Practice, and Quality, Children's National 
Health System, Washington, District of Columbia, USA; Department of Pediatrics, 
George Washington University, Washington, District of Columbia, USA. 
8Division of Pediatrics, Wilhelmina Children's Hospital (part of UMC Utrecht), Utrecht, 
Netherlands 
9 Department of Pharmacy, The Hospital for Sick Children, Toronto, ON 
2 
 
10Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON  
 
Corresponding Author: 
Lillian Sung, MD, PhD 
Division of Haematology/Oncology 
The Hospital for Sick Children 
555 University Avenue, Toronto, Ontario 
M5G1X8 
Telephone: 416-813-5287     
Fax: 416-813-5979   
Email: lillian.sung@sickkids.ca 
 
Running Head: Physical activity interventions for fatigue 
 
Word Counts: Abstract 150; Text 3,114; Tables 3; Figure 2; Appendices 4 
 
Key words: Fatigue, cancer, exercise, physical activity, randomized trial, meta-analysis  
 
Contributors: 
Study concept: SO, PR, LS 
Study design: SO, PR, LS 
Data acquisition: SO, PR, LLD, LS 
Quality control: SO, PR, LLD, LS 
Data analysis and interpretation: SO, PR, LS 
Statistical analysis: SO, PR, LS 
Manuscript preparation: SO, PR, LS 
3 
 
Manuscript editing: All 
Manuscript review and approval of the final version: All 
  
4 
 
TABLE OF CONTENTS 
Section Page 
Abstract 5 
Introduction 6 
Methods 7 
Results 12 
Discussion 14 
References 18 
Tables 21 
Figures  24 
 
  
5 
 
ABSTRACT 
Purpose: Objective was to determine whether physical activity reduces the severity of 
fatigue in patients with cancer or hematopoietic stem cell transplant (HSCT) recipients.  
Methods: We conducted a meta-analysis of randomized trials comparing physical 
activity with control interventions for the management of fatigue in patients with cancer 
or HSCT recipients. .  
Results:  There were 170 trials included. Physical activity reduced the severity of fatigue 
when compared to all control groups (standardized mean difference -0.49, 95% 
confidence interval -0.60 to -0.37; P<0.00001). Aerobic, neuromotor, resistance and 
combination exercises were all effective in reducing fatigue although smaller effects 
were observed with resistance exercises (P interaction=0.01). Other intervention and 
patient characteristics did not influence the effect of physical activity on the severity of 
fatigue.  
Conclusions: Physical activity was effective at reducing fatigue in patients with cancer 
and HSCT recipients across patient sub-groups. Determining the best approaches for 
safe implementation should be a priority.  
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INTRODUCTION 
 
Cancer-related fatigue (CRF) can be defined as a “distressing, persistent, 
subjective sense of physical, emotional or cognitive tiredness or exhaustion related to 
cancer or cancer treatment that is not proportional to recent activity and interferes with 
usual functioning”.[1] CRF affects up to 80-90% of adult cancer patients, and can occur 
prior to diagnosis, during cancer treatment and following the completion of cancer 
therapies.[2-6] Although the prevalence of CRF is less certain among children with 
cancer, 50 to 76% of children will experience fatigue.[7-9]  
The etiology of CRF is multifactorial and fatigue may result from cancer itself, 
treatments such as chemotherapy, radiotherapy or surgery, and comorbid medical and 
psychological conditions.[1, 10] Recipients of hematopoietic stem cell transplantation 
(HSCT) also experience fatigue, likely related to similar underlying mechanisms.[11, 12]  
Fatigue adversely affects the physical, mental and social health of patients with cancer, 
and consequently reduces quality of life.[3, 6, 13] It not only limits the ability to perform 
daily routines but also affects the desire to continue treatment, participate in social 
activities, perform cognitive tasks, and retain employment status.[5, 6, 14] 
A number of approaches have been investigated for the management of fatigue 
in cancer patients including physical activity.[1, 15, 16] Physical activity may be effective 
at reducing fatigue by decreasing inflammation, increasing muscle strength or mass and 
improving functional capacity and mental health.[17, 18] There are several systematic 
reviews, which have focused on the effect of physical activity on fatigue.[16, 19-25] 
However, none has included all randomized trials of physical activity, and thus, they had 
limited power to identify which patients may benefit from physical activity and which 
interventions may be more effective. Such analyses are important in order to create 
recommendations on how physical activity should be used in clinical practice for the 
management of fatigue.  
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Consequently, our primary objective was to determine whether physical activity 
reduces the severity of fatigue in adults and children with cancer or HSCT recipients as 
compared to control interventions. Our secondary objective was to determine whether 
the effect of physical activity on fatigue varied by patient, intervention or methodological 
factors.  
 
METHODS 
We followed the Preferred Reporting Items for Systematic Reviews and Meta- 
analyses (PRISMA) statement for this systematic review. We searched for eligible trials 
indexed from 1980 to May 11, 2017 in the following electronic databases: MEDLINE, 
MEDLINE in-process, Embase, Cochrane Central Register of Controlled Trials, CINAHL, 
and PsychINFO. The search strategy included a combination of Medical Subject 
Heading terms and text words to identify adults and children with cancer or HSCT 
recipients who received an intervention to reduce fatigue. The search strategy is 
available as Appendix 1. 
 
Study Selection and Data Abstraction 
We defined inclusion and exclusion criteria a priori. Studies were included if 
participants were adults or children with cancer or HSCT recipients, and if the study was 
a fully published primary randomized or quasi-randomized trial with a parallel group 
design. Studies had to evaluate an intervention for the management of fatigue. Studies 
were excluded if they: (1) were not randomized or quasi-randomized with a parallel 
group design; (2) were not a full-text publication; (3) included fewer than 75% of patients 
with cancer or undergoing HSCT; (4) did not include fatigue as an end point; or (5) were 
a duplicate publication. Included studies were not restricted by language or publication 
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status. For the purpose of this analysis, we then limited studies to those which evaluated 
a physical activity intervention. 
Three reviewers (SO, PDR or LS) independently evaluated the titles and 
abstracts of publications identified by the search. Any publication considered potentially 
relevant by either reviewer was retrieved in full and assessed for eligibility. Inclusion of 
studies in this meta-analysis was determined by agreement of both reviewers. 
Discrepancies between the two reviewers were resolved by consensus and adjudication 
by a third reviewer if required (LLD or LS). The Kappa statistic was used to evaluate 
agreement in study inclusion between the two reviewers. Strength of agreement was 
defined as slight (0.00 to 0.20), fair (0.21 to 0.40), moderate (0.41 to 0.60), substantial 
(0.61 to 0.80), or almost perfect (0.81 to 1.00).[26] 
Data were abstracted in duplicate by two reviewers (SO and PDR) and any 
discrepancies were resolved by consensus and adjudication by a third reviewer if 
required (LS). We contacted authors in the event of missing primary outcome data.  
 
Outcomes  
The primary outcome was the severity of self-report fatigue across different 
fatigue scales at the end of the intervention. For studies that used more than one fatigue 
scale, we a priori defined a hierarchy of which scale to use in the primary analysis. We 
ordered the scales according to prevalence in this systematic review (Appendix 2), and 
chose the most commonly used scale. The secondary outcomes were the severity of 
self-report fatigue using the three most common fatigue scales, namely the Functional 
Assessment of Cancer Therapy (FACT) (13-item fatigue subscale), the European 
Organisation for Research and Treatment Quality of Life Questionnaire - C30 (EORTC 
QLQ-C30) (fatigue subscale) and the Brief Fatigue Inventory (BFI) scale. 
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Physical Activity Interventions  
The intervention was physical activity of any type, intensity, frequency, or 
duration, used for the management of fatigue. We defined physical activity as any bodily 
movement produced by skeletal muscles, which results in energy expenditure above 
resting (basal) levels.[27] Physical activity interventions were categorized using the 
American College of Sports Medicine[27] approach as follows: (1) aerobic – 
includes brisk walking, running, cycling, climbing stairs, working out in a gym using a 
treadmill, stationary bike or elliptical machine, water aerobics, aerobic dance and hiking; 
(2) neuromotor – includes yoga, tai chi and qigong; (3) resistance – includes use of free 
weights and dumbbells, machines with stacked weights or pneumatic resistance, elastic 
tubing and resistance bands; and (4) flexibility –  includes ballistic stretches, 
dynamic stretching, and static stretching. Studies that used two or more discrete modes 
of physical activity such as combining aerobic or neuromotor were classified as 
combination. Because aerobic and neuromotor activities often include stretching, 
flexibility was only categorized if it was used alone. Studies that did not state the type of 
physical activity intervention were classified as unspecified. 
Characteristics of the physical activity interventions were described as follows. 
The mode of intervention delivery was categorized as supervised when the activity was 
performed under the direct supervision of an instructor and non-supervised otherwise. 
The delivery setting was classified as group when the intervention was delivered to more 
than one target participant at the same time. The number of weeks of physical activity 
intervention was dichotomized at 12 as this was the median duration of exercise used by 
the included studies. The minutes of physical activity per week was dichotomized at 150 
as this duration has been recommended for low to moderate intensity exercise in healthy 
adults.[27-29]  
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Control Groups 
We categorized control group type as: (1) usual care or wait list control; (2) 
physical activity when studies compared two different types of physical activities such as 
aerobic vs. resistance; (3) non-physical activity, active control (not usual care or wait list 
control) such as psychological, pharmacological or mind and body interventions; and (4) 
combination (physical activity and non-physical activity, active control). Among trials 
comparing two different types of physical activities, the activity of lower intensity was 
chosen as the control arm. For example, in a study comparing aerobic exercise and 
yoga, yoga was designated as the control arm.  
 
Study Characteristics and Risk of Bias Assessment 
Study-level variables included year of publication and enrollment, country of 
study, age of participants (adults vs. children), type of cancer (breast, prostate, other 
cancer and more than one cancer type), cancer stage (non-metastatic, metastatic and 
both), inclusion of HSCT recipients, timing of intervention (during cancer treatment, 
following completion of treatment or both during and following treatment), exclusive 
enrollment of palliative care patients (defined by each study), presence of fatigue as an 
eligibility criterion for enrollment (threshold varied by study) and characteristics of the 
intervention and control groups. 
We used the Cochrane Collaboration’s tool for assessing the risk of bias in 
randomized trials.[30] This approach evaluates sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcome assessors, 
attrition bias and selective reporting. Calculation of a total quality score and stratification 
of results by study quality (low vs. high quality) leads to unreliable results.[31]  For this 
reason we chose to adopt the suggestions of the Cochrane Collaboration[32] and forego 
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calculation of a total quality score and to evaluate quality domains separately. 
 
Data Analysis  
We combined data at the study level for this meta-analysis. For fatigue scores 
with missing summary measures, we made the following assumptions to facilitate data 
synthesis: the mean can be approximated by the median; the range contains six 
standard deviations (SDs); the 95% confidence interval (CI) contains four standard 
errors, and the interquartile range contains 1.35 SDs.  
For the primary analysis, we compared physical activity interventions vs. all 
controls across different fatigue scales and by the three most common fatigue scales. 
We then stratified these analyses by control group type: physical activity intervention vs. 
usual care or wait list control, physical activity intervention vs. physical activity control, 
and physical activity intervention vs non-physical activity, active control (psychological, 
pharmacological or mind and body interventions). For analyses across different fatigue 
scales, data were synthesized using the standardized mean difference (SMD) after 
rescaling such that higher scores reflected more fatigue. For analyses focused on 
specific fatigue scales, data were synthesized using the weighted mean difference 
(WMD). A SMD or WMD less than 0 indicate that the mean fatigue scores were lower 
(better) in the physical activity group as compared to the control group. Effects were 
weighted by the inverse variance. As we anticipated heterogeneity between studies, a 
random effects model was used for all analyses. Statistical heterogeneity between trials 
was assessed using the I2 value, which describes the percentage of total variation 
across studies due to heterogeneity rather than chance.  
 For the secondary objective, which was to determine whether the effect of 
physical activity varied by patient, intervention or methodological factors, we conducted 
stratified analyses. These stratified analyses focused on synthesis across fatigue scales 
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(and thus relied upon SMD) and compared physical activity interventions vs. all control 
groups and physical activity interventions vs. usual care or wait list controls separately. 
We evaluated the following factors for stratified analyses: (1) type of cancer, (2) cancer 
stage, (3) timing of intervention, (4) required fatigue for eligibility, (5) physical activity 
intervention type, (6) supervised vs. non-supervised physical activity intervention, (7) 
group vs. non-group delivery setting, (8) number of weeks of physical activity 
intervention, (9) minutes per week of physical activity intervention, (10) adequate 
sequence generation, and (11) adequate allocation concealment. We determined 
whether the physical activity effect varied by subgroups using the P value for interaction. 
Potential publication bias was explored by visual inspection of funnel plots when 
at least 10 studies were available for synthesis.[30] In the event of potential publication 
bias, the ‘‘trim and fill’’ technique was used to determine the impact of potential bias.[33] 
With this technique, outlying studies are deleted, and hypothetical negative studies with 
equal weight are created. Meta-analyses were conducted using Review Manager 5.2 
(Cochrane Collaboration, Nordic Cochrane Centre). 
 
RESULTS 
The flow diagram of study identification and selection is presented as Figure 1. 
The search strategy identified 11,793 citations, of which 617 were retrieved for full-text 
evaluation. Of these citations, 170 met the eligibility criteria and were included in this 
systematic review. Reasons for exclusion are described in Figure 1. Agreement of study 
inclusion between the two reviewers was almost perfect (kappa = 0.97, 95% CI 0.95 to 
0.99). 
Table 1 and Appendix 3 describe the characteristics of the 170 included studies. 
These studies were conducted in 27 countries. Half of the trials (51.7%) were published 
after 2013. Only one study was conducted in children and adolescents; it compared 
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aerobic exercise with usual care. Studies of breast cancer patients were the most 
common (47.1%). Physical activity intervention types were aerobic (44.7%), neuromotor 
(16.5%), resistance (8.8%) and combination (27.1%). Five studies (2.9%) did not specify 
the type of physical activity intervention used. Control group types were usual care or 
wait list (77.1%), other physical activity (16.5%), non-physical activity, active control 
(5.3%) and combination (1.2%). The non-physical activity, active controls were 
relaxation (n=5), psychological therapy (n=3), and breathing exercises (n=1). Fatigue 
assessment scales used across all the studies are listed in Appendix 2. Among the 27 
reported fatigue scales, the three most common were the FACT (13-item fatigue 
subscale) (n=58), EORTC QLQ-C30 (fatigue subscale) (n=30) and the BFI (n=21). 
Table 2 shows the effect of physical activity on fatigue severity across fatigue 
assessment scales and by specific fatigue scale for all control groups and stratified by 
control group type. One hundred and thirty-four studies encompassing 8927 patients 
were included in the comparison of physical activity intervention vs. all controls across 
fatigue scales. Overall, physical activity reduced the severity of fatigue when compared 
to all controls when measured using any fatigue scale (SMD -0.49, 95% CI -0.60 to -
0.37; P<0.00001, Figure 2) and when measured using FACT (WMD -3.40, 95% CI -5.25 
to -1.55; P=0.0003), EORTC QLQ-C30 (WMD -11.07 95% CI -17.79 to -4.36 P=0.002) 
and the BFI (WMD -0.53, 95% CI -0.93 to -0.13; P=0.009). When stratified by control 
group type, effects were generally similar irrespective of specific control group.  
 Table 3 shows the effect of physical activity intervention by patient, intervention 
and methodological factors stratified by all controls and by usual care or wait list controls. 
The effect of physical activity did not differ based upon type of cancer, cancer stage, 
timing of intervention and requirement of fatigue for eligibility. The following features of 
the intervention also did not influence the physical activity effect: supervised vs. non-
supervised, group vs. non-group setting, < 12 vs. ≥ 12 weeks of intervention, and <150 
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minutes/week vs. ≥ 150 minutes/week. However, the effect of physical activity on fatigue 
severity reduction differed by the type of physical activity performed when compared to 
all controls (P for interaction=0.01) (Figure 2). The effect of resistance exercises (SMD -
0.21, 95% CI -0.35 to -0.07; P=0.004) was smaller although still statistically significant as 
compared to aerobic (SMD -0.36, 95% CI -0.52 to -0.21; P<0.00001), neuromotor (SMD 
-0.56, 95% CI -0.97 to -0.14; P=0.008), combination (SMD -0.61, 95% CI -0.80 to -0.42; 
P<0.00001) and unspecified (SMD -1.81, 95% CI -4.21 to 0.59; P=0.14) interventions. 
Similar effects were seen when physical activity intervention types were compared to 
usual care or wait list controls.  
 Appendix 4 illustrates the funnel plot of all physical activity interventions against 
all controls across different fatigue scales. There was no suggestion of publication bias.  
 
DISCUSSION 
In this meta-analysis, we found that physical activity significantly decreases the 
severity of fatigue in patients with cancer and HSCT recipients. The effect was 
significant when all scales were combined and when evaluated by the three most 
common scales. Aerobic, neuromotor, resistance and combination exercises were all 
effective in reducing fatigue although smaller effects were observed with resistance 
exercises compared with the other physical activity approaches. The effect of physical 
activity did not differ based upon presence of fatigue at the time of the intervention, or 
whether the intervention was supervised, conducted in a group or its duration in weeks 
or minutes per week.  
The overall impact of physical activity on fatigue was -0.49 SMD which is 
considered a moderate effect.[34, 35] The effect of physical activity as measured using 
FACT (13-item fatigue subscale) was 3.40, which is larger than the reported minimum 
clinically important difference of 3 points.[36] Similarly, an effect of 11.07 units measured 
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using EORTC QLQ-C30 (fatigue subscale) suggests a clinically relevant improvement in 
fatigue.[37-39] Together, these data suggest that the impact of physical activity on 
fatigue severity is important to patients.  
We found that all physical activity interventions, namely aerobic, neuromotor, 
resistance and combination, were significantly associated with improved fatigue severity 
in comparison to all controls. However, we also found a quantitative interaction with 
resistance training being less effective compared to the other physical activity 
interventions. This finding should be viewed cautiously as we performed many tests and 
there is a chance that the significant interaction test is related to the number of tests 
performed. However, even if a true interaction exists, these findings suggest that all 
interventions are effective and that if resistance is a patient’s preferred modality, it 
should be offered if safe. Otherwise, aerobic, neuromotor or combination exercises may 
be offered preferentially. 
We found that the benefits of physical activity were not dependent upon the type 
or stage of cancer nor did it depend on whether the intervention was administered during 
or following completion of treatment. In addition, physical activity appeared to be 
effective whether administered in the prophylactic or therapeutic setting as evidenced by 
a similar effect based upon studies that required a threshold level of fatigue for study 
inclusion. These findings suggest that physical activity should be encouraged throughout 
the treatment course to diverse groups of cancer and HSCT patients although our 
analysis lacked granularity in evaluating specific patient subgroups. Further, only 12 
studies were available for data synthesis in which fatigue was an eligibility criterion and 
thus, conclusions about similar efficacy in the prophylactic and therapeutic setting should 
be made cautiously. 
In addition, the benefit of physical activity on fatigue was not restricted to studies 
providing ≥ 12 weeks or ≥ 150 minutes per week of intervention. An important potential 
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confounder is intensity of physical activity intervention. Unfortunately, we could not 
abstract data on intensity of physical activity because included studies did not use 
standardized tools to measure this aspect. The American Society of Sports Medicine 
recommends 30 to 60 minutes of purposeful moderate intensity aerobic physical activity 
per day for healthy adults for the purpose of improving physical fitness and health.[27] 
Our findings suggest that when used for the purpose of fatigue reduction, shorter 
durations (< 150 minutes per week) may also be effective.  
Our meta-analysis improves upon two other systematic reviews that reported the 
effect of physical activity on CRF.[16, 20] We had broader inclusion criteria and 
synthesized data from 134 studies as compared to analyses published by Mustain et al 
and Cramp et al, which synthesized 79 and 38 studies respectively.[16, 20] Our review 
provides unique insights as we had sufficient power to evaluate sub-group effects and to 
describe effects by different control group types.  
We did not evaluate whether fatigue was the primary outcome of trials as 
articulation of primary vs. secondary outcomes is often not clear in publications. Further, 
researchers have described bias in outcome reporting and modifications to outcomes 
from protocol to publication;[40, 41] these modifications are influenced by study findings.  
Finally, whether fatigue was identified as a primary or secondary outcome should not 
have impacted on the efficacy of a specific intervention for fatigue reduction. 
The strength of our systematic review was the large number of included studies, 
which provided precision in describing the effect of physical activity both overall, and 
among specific subgroups. The sample size also increased power to detect significant 
interactions by patient, intervention and methodological factors. However, our systematic 
review must be interpreted in light of its limitations. Studies did not use common 
endpoints, and as a result, we had to rely upon describing the effects using SMDs, which 
are harder to interpret than WMDs. In our review, only one pediatric study was identified 
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and thus, these results may not be applicable to children. Finally, we observed 
heterogeneity in the effect across analyses and we were not able to explain 
heterogeneity by our a priori specified sub-group analyses. It is possible that a source of 
heterogeneity was related to different study designs. Thus, our results must be viewed 
cautiously in view of this issue. 
 In conclusion, physical activity was effective at reducing fatigue in patients with 
cancer and HSCT recipients across patient sub-groups. Physical activity should be 
widely promoted for the management of fatigue in this population. Determining the best 
approaches for safe implementation should be a priority.  
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 Effect of resistance is smaller than other physical activity interventions 
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Table 1: Characteristics of Included Studies in the Systematic Review (N=170) 
 
Characteristic  No. of Studies 
(%) 
Study Population  
     Adults   169 (99.4) 
 Children 1 (0.6) 
Type of Cancer   
     Breast      80 (47.1) 
     Prostate 19 (11.2) 
     More than one cancer 45 (26.5) 
     Other cancer types 26 (15.3) 
Cancer Stage*  
     Non-metastatic  93 (54.7) 
     Metastatic  7 (4.1) 
     Both  29 (17.1) 
Included Hematopoietic Stem Cell Transplant Recipients 13 (7.6) 
Timing of Intervention*  
     During cancer treatment  93 (54.7) 
     Following completion of treatment 39 (22.9) 
     Both during and following treatment 36 (21.2) 
Palliative Care Setting Only 2 (1.2) 
Required Fatigue for Eligibility 15 (8.8) 
Physical Activity Intervention Type  
     Aerobic  76 (44.7) 
     Neuromotor  28 (16.5) 
     Resistance  15 (8.8) 
     Flexibility 0 (0) 
     Combination  46 (27.1) 
     Unspecified 5 (2.9) 
Mode of Physical Activity Intervention Delivery*  
     Supervised 110 (64.7) 
     Non-supervised 58 (34.1) 
Delivery Setting  
      Group 47(27.6) 
      Non-group 73(42.9) 
Number of Weeks - Physical Activity Intervention*  
     <12 weeks 56 (32.9) 
     ≥12 weeks 91 (53.5) 
Minutes per Week – Physical Activity Intervention*  
     <150 minutes 39 (22.9) 
     ≥150 minutes 88 (51.7) 
Control Group Type  
     Usual care or wait list 131 (77.1) 
     Physical activity  28 (16.5) 
     Non-physical activity, active control 9 (5.3) 
     Combination  2 (1.2) 
Risk of Bias  
     Adequate sequence generation 109 (64.1) 
     Adequate allocation concealment 69 (40.6) 
     Participants and personnel blinded   0 (0) 
     Outcome assessors blinded 0 (0) 
     Lack of attrition bias 103 (60.6) 
     Free of selective reporting 119 (70) 
 
* Does not add to 170 because not all the studies report this information 
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Table 2: Effect of Physical Activity Intervention on Fatigue Stratified by Fatigue Scale and Control Group Type 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: CI – confidence interval; FACT - Functional Assessment of Cancer Therapy; SMD - standardized mean difference; WMD - weighted mean difference 
* Non-physical activity, active controls were relaxation (n=5), psychological therapy (n=3), and breathing exercises (n=1) 
 
 
 
 
 
Outcome  No. of 
Studies 
No. of 
Patients 
Effect 95% CI I2 (%) P Value 
All Controls 
      
Physical Activity Intervention vs. All Controls       
   Any fatigue scale 134 8927 -0.49 SMD -0.60, -0.37 85 <0.00001 
   FACT (13-item fatigue subscale) 45 3295 -3.40 WMD -5.25, -1.55 89 0.0003 
   EORTC QLQ-C30 fatigue scale 25 1693 -11.07 WMD -17.79, -4.36 91 0.002 
   Brief fatigue inventory 12 704 -0.53 WMD -0.93, -0.13 85 0.009 
Stratified by Control Group Type 
      
Physical Activity Intervention vs. Usual Care or 
Wait List Control  
      
   Any fatigue scale 101 6750 -0.54 SMD -0.68, -0.39 87 <0.00001 
   FACT (13-item fatigue subscale) 38 2701 -2.99 WMD -4.72, -1.27 84 0.0007 
   EORTC QLQ-C30 fatigue scale 11 732 -14.53 WMD -28.06, -1.00 95 0.04 
   Brief fatigue inventory 10 622 -0.53 WMD -0.95, -0.10 88 0.01 
       
Physical Activity Intervention vs. Physical 
Activity Control  
      
   Any fatigue scale 23 1463 -0.42 SMD -0.66, -0.18 78 0.0006 
   FACT (13-item fatigue subscale) 7 594 -5.49 WMD -11.64, 0.66 95 0.08 
   EORTC QLQ-C30 fatigue scale 11 662 -6.38 WMD -9.75, -3.00 0 0.002 
       
Physical Activity Intervention vs. Non-Physical 
Activity, Active Control*  
      
   Any fatigue scale 9 651 -0.24 SMD -0.54, 0.07 72 0.13 
   EORTC QLQ-C30 fatigue scale 3 299 -10.76 WMD -20.04, -1.48 62 0.02 
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Table 3: Effect of Physical Activity Intervention by Patient, Intervention and Methodological Factors Stratified by Control Group Type 
  
 Physical Activity Intervention vs. All Control Groups Physical Activity Intervention vs. Usual Care or Wait List Control Groups 
 
Subgroup 
No. of 
Studies 
No. of 
Patients 
SMD* 95% CI I2 P Values 
No. of 
Studies 
No. of 
Patients 
SMD* 95% CI I2 P Values 
Type of cancer       
Pint=0.09 
     
Pint=0.25 
Breast 57 4110 -0.43 -0.58, -0.28 80 <0.00001 41 2884 -0.53 -0.72, -0.34 83 <0.00001 
Prostate 17 1078 -0.92 -1.35, -0.50 90 <0.0001 14 894 -0.77 -1.15, -0.38 86 <0.001 
Other cancer types 23 1269 -0.60 -1.11, -0.09 94 0.02 20 1058 -0.70 -1.30, -0.10 94 0.02 
More than one cancer 37 2470 -0.37 -0.51, -0.24 59 <0.00001 26 1914 -0.38 -0.56, -0.20 70 <0.0001 
Cancer stage      
Pint=0.45 
     
Pint-0.53 
     Non-metastatic 75 5200 -0.56 -0.74., -0.38 89 
<0.00001 
58 4069 -0.59 -0.80, -0.39 90 
<0.00001 
     Metastatic 4 116 -0.39 -0.85, 0.07 32 
0.1 
3 80 -0.40 -1.07, 0.27 51 
0.24 
     Both 23 1706 -0.38 -0.61, -0.15 79 
0.001 
20 1340 -0.41 -0.68, -0.13 83 
0.004 
Timing of Intervention      
Pint=0.51 
     
Pint=0.54 
During cancer treatment 74 5127 -0.52 -0.70, -0.34 89 <0.00001 58 4140 -0.51 -0.72, -0.30 90 <0.00001 
Following completion of 
treatment 
29 1518 -0.38 -0.58, -0.18 68 0.0002 19 1073 -0.49 -0.76, -0.23 73 0.0002 
Both during and following 
treatment 
29 2248 -0.53 -0.73, -0.32 81 <0.00001 22 1503 -0.67 -0.92, -0.43 80 <0.00001 
Required Fatigue for Eligibility      
Pint=0.74 
     
Pint=0.54 
Yes 12 549 -0.55 -0.91, -0.19 75 0.003 8 331 -0.67 -1.10, -0.24 69 0.002 
No 122 8378 -0.48 -0.61, -0.36 86 <0.00001 93 6419 -0.53 -0.68, -0.38 87 <0.00001 
Physical Activity Intervention 
Type 
     
Pint=0.01 
     
Pint=0.09 
 Aerobic  59 3624 -0.36 -0.52, -0.21 80 <0.00001 44 2851 -0.45 -0.64, -0.25 83 <0.00001 
 Neuromotor  24 1601 -0.56 -0.97, -0.14 93 0.008 20 1337 -0.54 -1.04, -0.04 94 0.04 
 Resistance  13 761 -0.21 -0.35, -0.07 0 0.004 7 323 -0.20 -0.42, 0.02 0 0.07 
 Combination exercises 35 2803 -0.61 -0.80, -0.42 83 <0.00001 27 2101 -0.59 -0.78 -0.40 76 <0.00001 
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Unspecified  3 138 -1.81 -4.21, 0.59 96 0.14 3 138 -1.81 -4.21, 0.59 96 0.14 
Mode of Physical Activity 
Intervention Delivery 
     
Pint=0.35 
     
Pint=0.16 
Supervised 95 6353 -0.53 -0.67, -0.38 86 <0.00001 67 4534 -0.56 -0.75, -0.38 88 <0.00001 
Non-supervised 38 2623 -0.41 -0.61, -0.21 82 <0.0001 34 2298 -0.50 -0.73, -0.28 87 <0.00001 
Delivery setting      
Pint-0.85 
     
Pint=0.99 
     Group 49 3662 -0.57 -0.76, -0.39 85 
<0.00001 
36 2791 -0.60 -0.80, -0.41 83 
<0.00001 
     Non-group 44 2819 -0.54 -0.81, -0.27 91 
<0.0001 
38 2233 -0.60 -0.92, -0.29 91 
0.0002 
Number of Weeks - Physical 
Activity Intervention 
     
Pint=0.22 
     
Pint=0.16 
< 12 weeks 46 2627 -0.59 -0.85, -0.34 89 <0.00001 36 2230 -0.66 -0.97, -0.35 91 <0.0001 
≥ 12 weeks 72 5215 -0.41 -0.54, -0.28 79 <0.00001 54 3730 -0.42 -0.57, -0.26 79 <0.00001 
Minutes per Week – Physical 
Activity Intervention 
     
Pint=0.69 
     
Pint=0.70 
< 150 minutes 30 1665 -0.50 -0.72, -0.28 75 <0.00001 20 1115 -0.64 -0.94, -0.33 80 <0.0001 
≥ 150 minutes 72 5118 -0.56 -0.74, -0.37 89 <0.00001 55 4006 -0.56 -0.78, -0.34 90 <0.00001 
Adequate Sequence 
Generation 
     
Pint=0.52 
     
Pint=0.99 
Yes 91 6355 -0.51 -0.66 -0.35 88 <0.00001 70 4857 -0.53 -0.71, -0.35 89 <0.00001 
No 43 2572 -0.43 -0.60, -0.26 75 <0.00001 31 1893 -0.53 -0.74, -0.31 79 <0.00001 
Adequate Allocation 
Concealment 
     
Pint=0.20 
     
Pint=0.65 
Yes 61 4409 -0.57 -0.77, -0.37 90 <0.00001 48 3424 -0.56 -0.79, -0.34 90 <0.00001 
No 73 4518 -0.41 -0.54 -0.28 78 <0.00001 53 3326 -0.50 -0.68, -0.32 82 <0.00001 
 
* Effect reflects SMD using any fatigue scale 
Abbreviations: CI – confidence interval; Pint – P value for interaction; SMD – standardized mean difference; 
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Figure 1: Flow diagram Depicting Study Identification, Selection and Reasons for Exclusion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11,793 citations screened by 
title/abstract  
2,263 duplicates removed  
11,176 citations excluded as did not 
meet eligibility criteria  
617 full-text papers retrieved for 
detailed evaluation  
173 excluded  
   21 not fully published (abstract or thesis) 
   34 not parallel group RCT 
     3 less than 75% of patients had cancer  
     2 less than 5 patients randomized to any arm 
    10 fatigue not a study endpoint or as AE 
     1 intervention direct cancer therapy 
   91 duplicate or companion publication  
     2 unable to translate 
     9 not retrievable 
      
 
444 studies identified as 
potentially eligible  
14,056 potentially relevant 
references identified  
170 included studies 
282 excluded as not a physical 
activity intervention  
8 studies included from 
review of SRs 
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Figure 2: Forest plot of studies comparing all physical activity interventions vs. all 
controls stratified by type of physical activity intervention   
 
Squares to the left of the vertical line mean that the physical activity is better than control. 
Horizontal lines through the squares represent 95% confidence intervals (CIs). The size 
of the squares reflects each study’s relative weight, and the diamond represents the 
aggregate standardized mean difference (SMD) and 95% CI.  
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